Overall rank by patents
#16,993
Across all tracked assignees
USPTO PatentsView assignee record - 17 granted patents across 13 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A23L (FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF).
The verdict
Mycotechnology holds 17 US patents across 13 technology areas, rank #16,993 of 50,000 tracked assignees.
Mycotechnology, Inc has been granted 17 US utility patents between 2015 and 2024, placing Mycotechnology, Inc at rank #16,993 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.0 claims per patent with primary concentration in A23L (FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF). As a US Corporation, Mycotechnology, Inc is one of the more focused assignees in the PatentsView dataset. By volume, Mycotechnology sits between Mogam Institute FOR Biomedical Research (17 patents, rank #16,989) and Marco Systemanalyse Und Entwicklung Gmbh (17 patents, rank #16,997) - the closest US assignees by grant volume. The composite Innovation Score of 42.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 11 grants, compared with 6 in the 2015–2019 window, a +83% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Mycotechnology, Inc's 18.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Mycotechnology, Inc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH
17 patents
MUNIYAL AYURVEDIC RESEARCH CENTRE
17 patents
MUSIC NOMAD, LLC
17 patents
MYCARTIS N.V.
17 patents
Magnomatics Limited
17 patents
Mainhouse (Xiamen) Electronics Co., Ltd.
17 patents
Malvern Instruments Limited
17 patents
Marco Systemanalyse und Entwicklung GmbH
17 patents
MYCOTECHNOLOGY, INC
17 patents
What this shows Mycotechnology holds 17 patents at rank #16,993, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #16,993 in granted patent volume.
Other assignees with the most granted patents in Mycotechnology's primary technology class.
Mycotechnology's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
43 Top 29% higher than 71% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 5.9% |
| 2016 | 1 | 5.9% |
| 2017 | 2 | 11.8% |
| 2018 | 1 | 5.9% |
| 2019 | 1 | 5.9% |
| 2020 | 2 | 11.8% |
| 2021 | 2 | 11.8% |
| 2022 | 2 | 11.8% |
| 2024 | 5 | 29.4% |
Top 13 of 13 technology areas
Overall rank by patents
#16,993
Across all tracked assignees
42.9 out of 100
How to use this portfolio
Mycotechnology's 17 grants land it in the top 29% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.